Bruker Corporation

Bruker's 16.12% short interest stands unusually high for a $5.6B analytical instruments company, suggesting meaningful skepticism among bearish traders. With an RSI of 47.5, the stock sits in neutral technical territory—neither oversold nor overbought—which combined with the elevated short position creates potential squeeze dynamics if sentiment shifts. The absence of a P/E ratio hints at profitability concerns or restructuring, a red flag that warrants scrutiny into whether fundamental weakness justifies the bearish positioning or if shorts are mispricing a turnaround narrative. For a hardware-dependent laboratory equipment supplier, this combination of elevated shorting pressure and neutral momentum deserves careful assessment of recent earnings trends and competitive positioning.